-
141
Concurrent acute sensorimotor axonal neuropathy and disseminated encephalitis associated with in an adult patient with anti-MOG and anti-sulfatide antibodies: a case report
Published 2024-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
142
Review: Current treatment of vestibular, ocular motor disorders and nystagmus
Published 2009-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
143
Acknowledgements
Published 2008-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
144
A novel score for evaluating cerebral aneurysms treated with flow diversion: 4F-flow diversion predictive score
Published 2021-08-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
145
Natalizumab in pediatric multiple sclerosis patients
Published 2010-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
146
Treatment of walking impairment in multiple sclerosis with dalfampridine
Published 2011-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
147
Evaluation of rAAVrh74 gene therapy vector seroprevalence by measurement of total binding antibodies in patients with Duchenne muscular dystrophy
Published 2023-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
148
Ocrelizumab: a new milestone in multiple sclerosis therapy
Published 2018-05-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
149
Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis
Published 2019-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
150
Independent risk factors for in-hospital outcome of myasthenic crisis: a prospective cohort study
Published 2024-02-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
151
Improving pediatric multiple sclerosis interventional phase III study design: a meta-analysis
Published 2022-04-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
152
Pipeline Embolization Device for intracranial aneurysms in a large Chinese cohort: factors related to aneurysm occlusion
Published 2020-10-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
153
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany
Published 2012-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
154
A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/ hereditary inclusion body myopathy, a sugar-deficient myopathy: a review
Published 2010-03-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
155
Review: Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms
Published 2009-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
156
Kynurenines and other novel therapeutic strategies in the treatment of dementia
Published 2013-11-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
157
Therapeutic advances in the management of Pompe disease and other metabolic myopathies
Published 2013-09-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
158
Real-world comparative safety and efficacy of tenecteplase alteplase in acute ischemic stroke patients with large vessel occlusion
Published 2021-01-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
159
Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world
Published 2017-10-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article -
160
The management of patent foramen ovale in divers: where do we stand?
Published 2022-07-01“…Therapeutic Advances in Neurological Disorders…”
Get full text
Article